	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.70	0.53	0.56	32.1%	25.0%
Operating Profit Qtr	-0.32	-0.28	-0.39	-14.3%	17.9%
Net Profit Qtr	-0.07	0.02	0.37	-450.0%	-118.9%
Earning Per Share Adjusted latest Qtr	-0.14	0.03	0.74	-566.7%	-118.9%

* Standalone data

Detailed Results

Emmessar Biotech & Nutrition Ltd.

24 Apr 2025

34.65

-1.08%

Board Meeting

Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Outcome for Financial Results For The …

BSE India

Please refer attachment

pdf

Emmessar Biotech & Nutrition Ltd.

17 Apr 2025

34.65

-1.08%

Corp. Note

Emmessar Biotech & Nutrition Ltd - 524768 - Format of the Initial Disclosure to be made …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyEmmessar Biotech & Nutrition Ltd 2CIN NO.L24110MH1992PLC065942 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Priyanka Sharma Designation: Company Secretary EmailId: investors@ebnl.org Name of the Chief Financial Officer: Jeyaval Nadar Designation: CFO EmailId: bj@ebnl.org Date: 17/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Emmessar Biotech & Nutrition Ltd.

16 Apr 2025

34.65

-1.08%

Board Meeting

Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Consideration Of Audited Financial …

BSE India

Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 ,inter alia, to consider and approve Please refer attachment

pdf